290 related articles for article (PubMed ID: 24481705)
1. Nanotherapeutics--product development along the "nanomaterial" discussion.
Wacker MG
J Pharm Sci; 2014 Mar; 103(3):777-84. PubMed ID: 24481705
[TBL] [Abstract][Full Text] [Related]
2. Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review.
Tyner K; Sadrieh N
Methods Mol Biol; 2011; 697():17-31. PubMed ID: 21116951
[TBL] [Abstract][Full Text] [Related]
3. Dealing with nanosafety around the globe-Regulation vs. innovation.
Wacker MG; Proykova A; Santos GML
Int J Pharm; 2016 Jul; 509(1-2):95-106. PubMed ID: 27184102
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology in cosmetics.
Katz LM; Dewan K; Bronaugh RL
Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
[TBL] [Abstract][Full Text] [Related]
5. A brief review of the occurrence, use, and safety of food-related nanomaterials.
Magnuson BA; Jonaitis TS; Card JW
J Food Sci; 2011 Aug; 76(6):R126-33. PubMed ID: 22417518
[TBL] [Abstract][Full Text] [Related]
6. Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?
Musazzi UM; Marini V; Casiraghi A; Minghetti P
Drug Discov Today; 2017 Jun; 22(6):870-882. PubMed ID: 28189800
[TBL] [Abstract][Full Text] [Related]
7. Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.
Zolnik BS; Sadrieh N
Adv Drug Deliv Rev; 2009 Jun; 61(6):422-7. PubMed ID: 19389437
[TBL] [Abstract][Full Text] [Related]
8. The safety of nanostructured synthetic amorphous silica (SAS) as a food additive (E 551).
Fruijtier-Pölloth C
Arch Toxicol; 2016 Dec; 90(12):2885-2916. PubMed ID: 27699444
[TBL] [Abstract][Full Text] [Related]
9. Product quality for nanomaterials: current U.S. experience and perspective.
Tyner KM; Zou P; Yang X; Zhang H; Cruz CN; Lee SL
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(5):640-54. PubMed ID: 25641690
[TBL] [Abstract][Full Text] [Related]
10. Nanomaterials and regulation of cosmetics.
Bowman DM; van Calster G; Friedrichs S
Nat Nanotechnol; 2010 Feb; 5(2):92. PubMed ID: 20130584
[No Abstract] [Full Text] [Related]
11. [International trend of guidance for nanomaterial risk assessment].
Hirose A
Yakugaku Zasshi; 2013; 133(2):175-80. PubMed ID: 23370509
[TBL] [Abstract][Full Text] [Related]
12. Launching a new food product or dietary supplement in the United States: industrial, regulatory, and nutritional considerations.
Finley JW; Finley JW; Ellwood K; Hoadley J
Annu Rev Nutr; 2014; 34():421-47. PubMed ID: 24850389
[TBL] [Abstract][Full Text] [Related]
13. Nanomaterials in food and agriculture: An overview on their safety concerns and regulatory issues.
Jain A; Ranjan S; Dasgupta N; Ramalingam C
Crit Rev Food Sci Nutr; 2018 Jan; 58(2):297-317. PubMed ID: 27052385
[TBL] [Abstract][Full Text] [Related]
14. The logistical requirements of current FDA review: format of documentation requested.
Hattan D
Regul Toxicol Pharmacol; 1996 Dec; 24(3):232-5. PubMed ID: 8975750
[No Abstract] [Full Text] [Related]
15. Detection of nanomaterials in food and consumer products: bridging the gap from legislation to enforcement.
Stamm H; Gibson N; Anklam E
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012 Aug; 29(8):1175-82. PubMed ID: 22725966
[TBL] [Abstract][Full Text] [Related]
16. Regulatory acceptability of the minipig in the development of pharmaceuticals, chemicals and other products.
van der Laan JW; Brightwell J; McAnulty P; Ratky J; Stark C;
J Pharmacol Toxicol Methods; 2010; 62(3):184-95. PubMed ID: 20601024
[TBL] [Abstract][Full Text] [Related]
17. Considerations on the EU definition of a nanomaterial: science to support policy making.
Bleeker EA; de Jong WH; Geertsma RE; Groenewold M; Heugens EH; Koers-Jacquemijns M; van de Meent D; Popma JR; Rietveld AG; Wijnhoven SW; Cassee FR; Oomen AG
Regul Toxicol Pharmacol; 2013 Feb; 65(1):119-25. PubMed ID: 23200793
[TBL] [Abstract][Full Text] [Related]
18. How Has CDER Prepared for the Nano Revolution? A Review of Risk Assessment, Regulatory Research, and Guidance Activities.
Tyner KM; Zheng N; Choi S; Xu X; Zou P; Jiang W; Guo C; Cruz CN
AAPS J; 2017 Jul; 19(4):1071-1083. PubMed ID: 28421428
[TBL] [Abstract][Full Text] [Related]
19. Nanotoxicology and nanomedicine: making hard decisions.
Linkov I; Satterstrom FK; Corey LM
Nanomedicine; 2008 Jun; 4(2):167-71. PubMed ID: 18329962
[TBL] [Abstract][Full Text] [Related]
20. Measuring nanoparticles size distribution in food and consumer products: a review.
Calzolai L; Gilliland D; Rossi F
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012 Aug; 29(8):1183-93. PubMed ID: 22725833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
